NCT00759161View on ClinicalTrials.gov

Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Psoriasis
Interventions
DRUG

AN2728

AN2728 Ointment, 5%, twice daily for 4 weeks

DRUG

AN2728 Ointment Vehicle

AN2728 Ointment Vehicle, twice daily for 4 weeks.

Trial Locations (1)

06700

IMIC, Mexico City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00759161 - Safety and Efficacy Study of A Novel Ointment to Treat Plaque Type Psoriasis | Biotech Hunter | Biotech Hunter